Available IPD datapackage for study 'A Long-term, Open-label, Flexible-dose, Extension Study Evaluating the Safety and Tolerability of [Vortioxetine] Lu AA21004 in Patients With Major Depressive Disorder'

The purpose of the study is to evaluate long-term safety and tolerability of Vortioxetine over a period of 52 weeks in patients with Major Depressive Disorder (MDD) having completed 8-week acute treatment.

本研究旨在评估伏硫西汀（Vortioxetine）在完成8周急性期治疗的重度抑郁症（MDD）患者中，为期52周的长期安全性与耐受性。